Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $67.1600 (-1.8%) ($66.2700 - $68.1000) on Tue. Mar. 14, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.99% (three month average) | RSI | 60 | Latest Price | $67.1600(-1.8%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 2.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IBB(35%) XLV(31%) XBI(30%) IVW(28%) IWF(28%) | Factors Impacting SGEN price | SGEN will decline at least -1.495% in a week (0% probabilities). VIXM(-12%) UUP(-6%) TLT(-3%) GDXJ(-2%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.495% (StdDev 2.99%) | Hourly BBV | 0 () | Intraday Trend | -0.1% | | | |
|
5 Day Moving Average | $67.61(-0.67%) | 10 Day Moving Average | $67.85(-1.02%) | 20 Day Moving Average | $66.35(1.22%) | To recent high | -2.5% | To recent low | 28.3% | Market Cap | $11.677b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |